Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Lowe

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 1992
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group studyP J Loehrer, L H Einhorn, P J Elson, et al.
Urology|July 11, 2001
Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235)O Kucuk, E Fisher, C M Moinpour, et al.
AJR. American Journal of Roentgenology|June 1, 1980
Low efficacy radiography of childrenJ J Seibert, E Bryant, B A Lowe, et al.
The New England Journal of Medicine|October 8, 1998
Bilateral orchiectomy with or without flutamide for metastatic prostate cancerM A Eisenberger, B A Blumenstein, E D Crawford, et al.
Urologic Oncology|January 13, 2011
Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group studyD L Lamm, B A Blumenstein, E David Crawford, et al.
Urology|July 1, 1996
Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trialM F Sarosdy, B A Lowe, P F Schellhammer, et al.
The Journal of Urology|March 29, 2000
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group StudyD L Lamm, B A Blumenstein, J D Crissman, et al.
Urologic Oncology|January 13, 2011
Prognostic significance of DNA ploidy in Ta/Tl bladder cancer: A southwest oncology group studyR W Devere White, A D Deitch, H Tesluk, et al.
European Urology|April 15, 2000
The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer. A Southwest Oncology Group StudyR W deVere White, A D Deitch, S Daneshmand, et al.
European Journal of Nuclear Medicine|April 13, 1999
Examining the immune response in sentinel lymph nodes of mice and menY Chu, H M Hu, H Winter, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 1992
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group studyP J Loehrer, L H Einhorn, P J Elson, et al.
Urology|July 11, 2001
Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235)O Kucuk, E Fisher, C M Moinpour, et al.
AJR. American Journal of Roentgenology|June 1, 1980
Low efficacy radiography of childrenJ J Seibert, E Bryant, B A Lowe, et al.
The New England Journal of Medicine|October 8, 1998
Bilateral orchiectomy with or without flutamide for metastatic prostate cancerM A Eisenberger, B A Blumenstein, E D Crawford, et al.
Urologic Oncology|January 13, 2011
Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group studyD L Lamm, B A Blumenstein, E David Crawford, et al.
Urology|July 1, 1996
Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trialM F Sarosdy, B A Lowe, P F Schellhammer, et al.
The Journal of Urology|March 29, 2000
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group StudyD L Lamm, B A Blumenstein, J D Crissman, et al.
Urologic Oncology|January 13, 2011
Prognostic significance of DNA ploidy in Ta/Tl bladder cancer: A southwest oncology group studyR W Devere White, A D Deitch, H Tesluk, et al.
European Urology|April 15, 2000
The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer. A Southwest Oncology Group StudyR W deVere White, A D Deitch, S Daneshmand, et al.
European Journal of Nuclear Medicine|April 13, 1999
Examining the immune response in sentinel lymph nodes of mice and menY Chu, H M Hu, H Winter, et al.
Pageof 5